logo
搜索
菜单

pharmacoki的搜索结果

当前1/7页
排序: 本月浏览数
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components 01:14 min
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components
13.12: Pharmacokinetics in Pediatric Patients: Drug Distribution 01:17 min
13.12: Pharmacokinetics in Pediatric Patients: Drug Distribution
25.8: Insulin Formulations: Types and Delivery 01:27 min
25.8: Insulin Formulations: Types and Delivery
17.13: Toxicokinetics: Overview 01:21 min
17.13: Toxicokinetics: Overview
16.5: Modified-Release Drug Delivery Systems: Drug Release Characteristics 01:22 min
16.5: Modified-Release Drug Delivery Systems: Drug Release Characteristics
16.4: Modified-Release Drug Delivery Systems: Bioavailability 01:30 min
16.4: Modified-Release Drug Delivery Systems: Bioavailability
16.3: Modified-Release Drug Delivery Systems: Influencing Factors 01:20 min
16.3: Modified-Release Drug Delivery Systems: Influencing Factors
15.16: Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions 01:15 min
15.16: Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
15.15: Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model 01:14 min
15.15: Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model 01:15 min
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model
15.9: Pharmacodynamic Models: Overview 01:27 min
15.9: Pharmacodynamic Models: Overview
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems 01:24 min
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect 01:28 min
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect 01:26 min
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
14.4: Pharmacogenetics of Drug Metabolism: Overview 01:27 min
14.4: Pharmacogenetics of Drug Metabolism: Overview
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu 01:29 min
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant 01:25 min
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08 min
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
13.15: Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow 01:26 min
13.15: Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
13.14: Pharmacokinetics in Pediatric Patients: Drug Excretion 01:26 min
13.14: Pharmacokinetics in Pediatric Patients: Drug Excretion
返回顶部